602 related articles for article (PubMed ID: 29483830)
1. The role of TGF-β/SMAD4 signaling in cancer.
Zhao M; Mishra L; Deng CX
Int J Biol Sci; 2018; 14(2):111-123. PubMed ID: 29483830
[TBL] [Abstract][Full Text] [Related]
2. SMAD4 and its role in pancreatic cancer.
Xia X; Wu W; Huang C; Cen G; Jiang T; Cao J; Huang K; Qiu Z
Tumour Biol; 2015 Jan; 36(1):111-9. PubMed ID: 25464861
[TBL] [Abstract][Full Text] [Related]
3. Smad4-mediated TGF-beta signaling in tumorigenesis.
Yang G; Yang X
Int J Biol Sci; 2010 Jan; 6(1):1-8. PubMed ID: 20087440
[TBL] [Abstract][Full Text] [Related]
4. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
[TBL] [Abstract][Full Text] [Related]
5. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Respiratory Factor-1, a Novel SMAD4 Binding Protein, Represses TGF-β/SMAD4 Signaling by Functioning as a Transcriptional Cofactor.
Rajasekaran N; Song K; Lee JH; Wei Y; Erkin ÖC; Lee H; Shin YK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070531
[TBL] [Abstract][Full Text] [Related]
9. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
[TBL] [Abstract][Full Text] [Related]
10. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
[TBL] [Abstract][Full Text] [Related]
11. AMBRA1 Promotes TGFβ Signaling via Nonproteolytic Polyubiquitylation of Smad4.
Liu J; Yuan B; Cao J; Luo H; Gu S; Zhang M; Ding R; Zhang L; Zhou F; Hung MC; Xu P; Lin X; Jin J; Feng XH
Cancer Res; 2021 Oct; 81(19):5007-5020. PubMed ID: 34362797
[TBL] [Abstract][Full Text] [Related]
12.
McCarthy AJ; Chetty R
J Clin Pathol; 2018 Aug; 71(8):661-664. PubMed ID: 29720405
[TBL] [Abstract][Full Text] [Related]
13. TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
Yang T; Huang T; Zhang D; Wang M; Wu B; Shang Y; Sattar S; Ding L; Liu Y; Jiang H; Liang Y; Zhou F; Wei Y
Aging (Albany NY); 2019 Oct; 11(20):8892-8910. PubMed ID: 31631064
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
15. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
16. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
Fullerton PT; Creighton CJ; Matzuk MM
Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
[TBL] [Abstract][Full Text] [Related]
17. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.
Zhang Q; Xiao M; Gu S; Xu Y; Liu T; Li H; Yu Y; Qin L; Zhu Y; Chen F; Wang Y; Ding C; Wu H; Ji H; Chen Z; Zu Y; Malkoski S; Li Y; Liang T; Ji J; Qin J; Xu P; Zhao B; Shen L; Lin X; Feng XH
Nat Cell Biol; 2019 Feb; 21(2):179-189. PubMed ID: 30664791
[TBL] [Abstract][Full Text] [Related]
18. The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
Azmi PB; Seth AK
Anticancer Res; 2009 Jun; 29(6):2253-63. PubMed ID: 19528490
[TBL] [Abstract][Full Text] [Related]
19. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
[TBL] [Abstract][Full Text] [Related]
20. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
Mishra L; Katuri V; Evans S
Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
